Davies P, Reuber M, Grunewald R, Howell S, et al. The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre. Seizure 2020;79:8-13.
PMID: 32380376